SEATTLE, WA--(Marketwired - Nov 2, 2016) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals (OTCQB: ATTBF) (CSE: ATT). The company recently announced the receipt of a Controlled Substance License from Health Canada for Northern Vine Laboratories, a company in which Abattis has a 75% stake. The Northern Vine lab site is built, security is in place, and all of the government inspections are complete. Once the lab's equipment is properly calibrated, Northern Vine will be open for business.
Initially, Northern Vine will be providing independent, neutral testing services to Licensed Producers as well as to individuals using medical marijuana under the current regulations. This will be the primary revenue source, and market indications show no shortage of demand for the services. Located in Langley, BC, Northern Vines is in the heart of the Vancouver-area market and will be one of the only testing facilities on the Lower Mainland.
Along with the safety testing services, Northern Vine can act as an incubator for product formulations and Intellectual Property development, either contractually for outside companies or for Abattis itself.
Northern Vine's long-anticipated federal license has moved the company from the hypothetical world into the real one. Combined with Abattis' ownership of its LP application in Quebec called Biocell Labs Inc., and its announcement of an agreement to acquire up to 100% of Experion Biotechnologies Inc., a Licensed Producer applicant in the Vancouver area, these developments reflect a comprehensive long-term plan. If any of the current or future LP applications go through, Abattis will have a production and distribution operation to complement Northern Vine's testing and product development capabilities.
Abattis' other established business, Vergence Sales and Marketing, already offers bioceutical products to consumers. With distribution in place and the groundwork being laid for additional Asian channels, Vergence completes the full circle of Abattis' plan to become a full service legal cannabis operation. From seed to sale, Abattis is putting together a comprehensive business right before our eyes.
Click here to read the full article: http://www.cannabisfn.com/abattis-federally-licensed-lab-and-the-crucial-role-it-plays/
Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.